Detalles de la búsqueda
1.
Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis.
Rheumatol Ther
; 11(1): 97-112, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982966
2.
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Rheumatol Ther
; 11(3): 737-753, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38683479
3.
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Rheumatol Ther
; 11(1): 157-175, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180720
4.
Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals.
Inhal Toxicol
; 20(13): 1179-89, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18802802
5.
Using school-level interviews to develop a Multisite PE intervention program.
Health Educ Behav
; 33(1): 52-65, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16397159
6.
Formative research in school and community-based health programs and studies: "state of the art" and the TAAG approach.
Health Educ Behav
; 33(1): 25-39, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16397157
Resultados
1 -
6
de 6
1
Próxima >
>>